Institutional Biosafety Committee
Consistent with the National Institutes of Health "Guidelines for Research Involving Recombinant DNA Molecules" and the Centers for Disease Control-National Institutes of Health "Guidelines for Biosafety in Microbiological and Biomedical Laboratories," it is the policy of Downstate Medical Center that all uses of recombinant DNA molecules, all organisms and viruses containing recombinant DNA and all microbiological and biomedical uses of the Human immunodeficiency Viruses and other pathogens be reviewed and approved by the Institutional Biosafety Committee to insure that all applicable safety standards are met.
When a research project involves the use of recombinant DNA molecules or other pathogens, the Principal Investigator should submit their research protocols to the Institutional Biosafety Committee prior to the sponsor's deadline. Early submission of the protocol to the committee is advisable to allow time for any necessary clarification, revision and reconsideration and final approval.
The following requirements are for all personnel named on IBC protocols:
Laboratory Safety Training
All laboratory personnel are required to complete the Laboratory Safety Training annually.
- To view the training module, please click this Lab Safety Training link
(use Google Chrome for optimal viewing).
- After viewing the module, users must complete the comprehension; Lab Safety Quiz.
CITI Program Biosafety and Biosecurity Training Modules
All laboratory personnel are required to complete the CITI modules every 3 years.
- Intro to Biosafety
- Basic Biosafety training
- Animal biosafety (only necessary if working with animals)
- OSHA Personal Protective Equipment
- Shipping and Transport of Regulated Biological Materials (only necessary if your lab will be shipping substances)